Medication info
Pitadus Tablets 4 mg (Pitavastatin Calcium)

Pitadus Tablets 4 mg (Pitavastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium›4mg / 1 tablet
Manufacturer / importer
Hanlim Pharmaceutical Co., Ltd.
Appearance
Pale yellow round film-coated tablet
Packaging
30 tablets (10 tablets/PTP packaging X 3), 100 tablets/bottle
Approval status
Active

MFDS item code 201310714 · Approved 2013.12.17 · Insurance code 645304760

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 mg per day. Depending on the LDL cholesterol level, treatment goal, and patient response, the dose should be adjusted as appropriate at intervals of 4 weeks or longer, and the therapeutic effect of this medicine is maintained with continued administration.

Ingredients

Manufacturer
Hanlim Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Hypercholesterolemia
  • dyslipidemia
  • elevated total cholesterol
  • elevated LDL-cholesterol
  • elevated apolipoprotein B
  • elevated triglycerides
View approved original text

This medication helps to lower total cholesterol and LDL-cholesterol, apolipoprotein B, and triglycerides in patients with primary hypercholesterolemia and mixed dyslipidemia while increasing HDL-cholesterol. It contributes to the prevention of cardiovascular diseases by improving blood lipid levels when used in conjunction with a dietary regimen. Therefore, this drug is effectively used for the treatment of dyslipidemia.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 mg per day. Depending on the LDL cholesterol level, treatment goal, and patient response, the dose should be adjusted as appropriate at intervals of 4 weeks or longer, and the therapeutic effect of this medicine is maintained with continued administration.

Precautions

This medication should not be used in certain patients. For example, patients with an allergy to any component of this drug, patients with active liver disease, patients with severe liver impairment or bile duct obstruction, and patients taking cyclosporine should not take this medication. Additionally, it should not be administered to patients with myopathies, pregnant women, women who might become pregnant, nursing mothers, and children. Patients with genetic issues like lactose intolerance should also avoid this medication. This medication should be administered with caution in patients with impaired kidney function or a history of liver disease, and in those who consume alcohol excessively. In particular, caution is required when taken in combination with fibrates or niacin due to the increased risk of muscle damage. Elderly individuals, patients with hypothyroidism, and those with a history of muscular disease should also be cautious. During the use of this medication, symptoms such as muscle pain, weakness, abdominal pain, rash, and itching may appear; if any abnormal symptoms occur, immediate notification of medical personnel is required. Regular liver function tests and blood tests should be conducted, and if there are signs of liver dysfunction, thrombocytopenia, or muscle damage, discontinuation of therapy is necessary. This medication may interact with other drugs, so caution is needed when used with cyclosporine, fibrates, niacin, and cholestyramine. Always consult medical personnel regarding other medications being taken. Elderly patients have decreased bodily functions and may experience adverse reactions more easily, so caution is needed during administration. Pregnant or nursing women should not take this medication, and women who could become pregnant should confirm their pregnancy status before taking it. The safety of this medication in children has not been established, therefore it is not used. This medication must be taken exactly as prescribed, and tablets should be swallowed whole without being divided. When storing, keep it out of the reach of children, and store it in its original container to maintain its quality. This medication can rarely cause serious muscle diseases; if muscle-related symptoms appear, immediate discontinuation and consultation with medical personnel are necessary.

Side effects

  • Abdominal pain
  • rash
  • malaise
  • paralysis
  • itching
  • muscle pain
  • weakness
  • elevated CPK levels
  • increased myoglobin in blood and urine
  • acute kidney failure
Show 80 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • urticaria
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST
  • elevated ALT
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • stiffness
  • drowsiness
  • insomnia
  • headache
  • heaviness in the head
  • dizziness
  • thirst
  • indigestion
  • abdominal bloating
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • gastric discomfort
  • diarrhea
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • increased globulin
  • positive Coombs test
  • anemia
  • increased urine
  • elevated BUN
  • elevated serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • elevated adrenocorticotropic hormone
  • increased cortisol
  • decreased testosterone
  • muscle cramps
  • flaccidity
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • urinary hematuria
  • elevated uric acid levels
  • increased serum potassium and phosphorus
  • taste disturbances
  • malaise
  • positive antinuclear antibody
  • sleep disturbances
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • immune-mediated necrotizing myopathy
  • myasthenia gravis
  • ocular myasthenia
  • facial edema
  • arm edema
  • hypersensitivity
  • headache
  • skin tingling
  • loss of appetite
  • increased blood pressure
  • chest discomfort
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a light-resistant container at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Pale yellow round film-coated tablet

Package unit

30 tablets (10 tablets/PTP packaging X 3), 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.